Windlas Biotech Limited Profit Margin

The latest profit margin for WINDLAS.NS is 7.05% as of June 2026. That compares with 8.2% in the prior-year period — down 14.0% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside Windlas Biotech Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, WINDLAS.NS's profit margin moved from 8.2% to 7.05% — a 14.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Windlas Biotech Limited's valuation or profitability profile.

Against its sector companies, WINDLAS.NS currently prints 7.05% for profit margin, while the sector average sits near 13.2%. That is roughly 46.6% below the sector mean. Large gaps often invite a closer look at Windlas Biotech Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Windlas Biotech Limited converts resources into returns. At 7.05%, WINDLAS.NS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 8.2% in the prior-year period — down 14.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting WINDLAS.NS's profit margin (7.05%), review year-over-year change from 8.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.